{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T05:20:44Z","timestamp":1736918444233,"version":"3.33.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","elsevier.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.remnie.2024.500055","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T04:18:21Z","timestamp":1725941901000},"page":"500055","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Low dose radioactive iodine ablation therapy (1.11GBq) for differentiated thyroid cancer in Western Turkey"],"prefix":"10.1016","volume":"43","author":[{"given":"B.","family":"Karasah Erkek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Sariyildiz Gumusgoz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Oral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Yazici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Akgun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.remnie.2024.500055_bib0005","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1089\/thy.2009.0110","article-title":"Revised American Thyroid Association Management Guidelines for patients with thyroid nodules and differentiated thyroid cancer","volume":"19","author":"Cooper","year":"2009","journal-title":"Thyroid"},{"issue":"1","key":"10.1016\/j.remnie.2024.500055_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/j.remnie.2024.500055_bib0015","doi-asserted-by":"crossref","first-page":"e1885","DOI":"10.1371\/journal.pone.0001885","article-title":"Low versus high radioiodine activity to ablate the thyroid after thyroidectomy for cancer: a randomized study","volume":"3","author":"Maenpaa","year":"2008","journal-title":"Plos One"},{"issue":"Suppl 1","key":"10.1016\/j.remnie.2024.500055_bib0020","article-title":"Estimabl2: Is There a Need for Radioiodine Ablation in Low Risk Differentiated Thyroid Cancer (DTC) Patients?: Results From the French Randomized Phase III Prospective Trial on 776 Patients (NCT 01837745)","volume":"5","author":"Leboulleux","year":"2021","journal-title":"J Endocr Soc."},{"issue":"4","key":"10.1016\/j.remnie.2024.500055_bib0025","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1210\/jc.2012-3682","article-title":"Low- or high-dose radioiodine remnant ablation for differentiated thyroid carcinoma: a meta-analysis","volume":"98","author":"Cheng","year":"2013","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.remnie.2024.500055_bib0030","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1530\/eje.0.1500105","article-title":"Follow\u2010up of low\u2010risk patients with differentiated thyroid carcinoma: a European perspective","volume":"150","author":"Schlumberger","year":"2004","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.remnie.2024.500055_bib0035","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/MNM.0b013e32834ec5d6","article-title":"Comparison of 800 and 3700 MBq iodine-131 for the postoperative ablation of thyroid remnant in patients with low-risk differentiated thyroid cancer","volume":"33","author":"Caglar","year":"2012","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.remnie.2024.500055_bib0040","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1056\/NEJMoa1109589","article-title":"Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer","volume":"366","author":"Mallick","year":"2012","journal-title":"N Engl J Med."},{"key":"10.1016\/j.remnie.2024.500055_bib0045","unstructured":"NCCN Clinical Practice Guidelines in oncology: Thyroid Carcinoma V1.2023.www.nccn.org."},{"issue":"6","key":"10.1016\/j.remnie.2024.500055_bib0050","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1089\/thy.2018.0775","article-title":"Risk for thyroid cancer recurrence is higher in men than in women independent of disease stage at presentation","volume":"30","author":"Zahedi","year":"2020","journal-title":"Thyroid."},{"key":"10.1016\/j.remnie.2024.500055_bib0055","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1210\/jc.2004-1771","article-title":"Serum thyroglobulin levels at the time of 131-I remnant ablation just after thyroidectomy are useful for early prediction of clinical recurrence in low-risk patients differentiated thyroid carcinoma","volume":"90","author":"Kim","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.remnie.2024.500055_bib0060","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/jso.10089","article-title":"Significance of postoperative serum thyroglobulin levels in patients with papillary and follicular thyroid carcinomas","volume":"80","author":"Lin","year":"2002","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.remnie.2024.500055_bib0065","first-page":"988","article-title":"Predictive value for disease progression of serum thyroglobulin levels measured in the postoperative period and after 131-I ablation therapy inpatients with differentiated thyroid cancer","volume":"45","author":"Toubeau","year":"2004","journal-title":"J Nucl Med"},{"key":"10.1016\/j.remnie.2024.500055_bib0070","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1365-2265.2006.02685.x","article-title":"Serum thyroglobulin concentrations predict disease-free remission and death in differentiated thyroid carcinoma","volume":"66","author":"Heemstra","year":"2007","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.remnie.2024.500055_bib0075","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1210\/jc.2003-031982","article-title":"Clinical behaviour and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: study of 289 cases","volume":"89","author":"Pellegriti","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.remnie.2024.500055_bib0080","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/MNM.0b013e328341c802","article-title":"Serum thyroglobulin predicts thyroid remnant ablation failure with 30 mCi iodine-131 treatment in patients with papillary thyroid carcinoma","volume":"32","author":"Tamilia","year":"2011","journal-title":"Nucl Med Commun."}],"container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253808924000818?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253808924000818?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T12:45:02Z","timestamp":1736858702000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2253808924000818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S2253808924000818"],"URL":"https:\/\/doi.org\/10.1016\/j.remnie.2024.500055","relation":{},"ISSN":["2253-8089"],"issn-type":[{"type":"print","value":"2253-8089"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low dose radioactive iodine ablation therapy (1.11GBq) for differentiated thyroid cancer in Western Turkey","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.remnie.2024.500055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.remn.2024.500055","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Sociedad Espa\u00f1ola de Medicina Nuclear e Imagen Molecular. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"500055"}}